Key result
Intensive treatment in older leukemia patients is linked to ~29% higher absolute overall survival versus palliation.
Why the study?
Older/elderly patients with acute lymphoblastic leukemia are poorly represented in clinical trials, and their disease characteristics, treatment choices, and outcomes need investigation.
Does intensive treatment improve complete remission and overall survival compared to a palliative approach in older patients with acute lymphoblastic leukemia?
Observational (n=174)
Yes
Does intensive treatment improve complete remission and overall survival compared to a palliative approach in older patients with acute lymphoblastic leukemia?
Absolute Event Rate: 32% vs 3%
In older patients with ALL, overall prognosis remains poor despite intensive and age-adapted treatments, though Philadelphia chromosome positivity does not confer a worse prognosis compared to Ph-negative disease.
No takes yet. Share an insight, caveat, or question.
Supports considering intensive therapy in selected older ALL patients; observational data leaves open need for randomized confirmation.
Kozlowski et al. (2017) conducted an observational in Acute lymphoblastic leukemia (ALL) (n=174). Intensive treatment vs. Palliative approach was evaluated on 3-year overall survival (OS). Intensive treatment in older patients with acute lymphoblastic leukemia resulted in a 3-year overall survival of 32% versus 3% with palliation, and Philadelphia positivity did not impair outcomes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: